Securities exhibited confidence in Axsome Therapeutics (NASDAQ:AXSM) by increasing the company's price target from $137.00 to $195.00. The firm has maintained an Outperform rating on the stock. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback